Clinical Trials
26 trialsStudying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
City of Hope Medical Center
Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients
Shahid Beheshti University of Medical Sciences
Assessment of Candidate Protein Expression in Breast Cancer Specimens
Case Comprehensive Cancer Center
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
Alliance for Clinical Trials in Oncology
Fibrotic Focus in Breast Cancer
Chinese University of Hong Kong
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
City of Hope Medical Center
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
Eastern Cooperative Oncology Group
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Eastern Cooperative Oncology Group
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Eastern Cooperative Oncology Group
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer
Wake Forest University Health Sciences
Biomarkers in Native American Women With Breast Cancer
Alliance for Clinical Trials in Oncology
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
National Cancer Institute (NCI)
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lapatinib Resistance in Patients With Breast Cancer
Case Comprehensive Cancer Center
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial
NSABP Foundation Inc
Spectroscopy of Breast Tissue
Case Comprehensive Cancer Center
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313
SWOG Cancer Research Network
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
National Cancer Institute (NCI)
Laser Spectroscopy of Breast Tissue Through a Needle Device
Case Comprehensive Cancer Center
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
National Cancer Institute (NCI)
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
Barbara Ann Karmanos Cancer Institute
Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100
Eastern Cooperative Oncology Group
Study of Ductal Lavage in Women at High Risk for Breast Cancer
University of California, San Francisco
IRB 2000-294
University of Michigan Rogel Cancer Center